DK174978B1 - Anvendelse af human koagulationsfaktor XIII til fremstilling af et lægemiddel til hindring af intraventrikulær blødning hos for tidligt fødte børn - Google Patents
Anvendelse af human koagulationsfaktor XIII til fremstilling af et lægemiddel til hindring af intraventrikulær blødning hos for tidligt fødte børn Download PDFInfo
- Publication number
- DK174978B1 DK174978B1 DK198900838A DK83889A DK174978B1 DK 174978 B1 DK174978 B1 DK 174978B1 DK 198900838 A DK198900838 A DK 198900838A DK 83889 A DK83889 A DK 83889A DK 174978 B1 DK174978 B1 DK 174978B1
- Authority
- DK
- Denmark
- Prior art keywords
- factor xiii
- coagulation factor
- drug
- precipitate
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/45—Transferases (2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Virology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Heart & Thoracic Surgery (AREA)
- Zoology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3964688 | 1988-02-24 | ||
| JP63039646A JPH01216939A (ja) | 1988-02-24 | 1988-02-24 | 末熟児頭蓋内出血阻止剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK83889D0 DK83889D0 (da) | 1989-02-23 |
| DK83889A DK83889A (da) | 1989-08-25 |
| DK174978B1 true DK174978B1 (da) | 2004-04-05 |
Family
ID=12558846
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK198900838A DK174978B1 (da) | 1988-02-24 | 1989-02-23 | Anvendelse af human koagulationsfaktor XIII til fremstilling af et lægemiddel til hindring af intraventrikulær blødning hos for tidligt fødte børn |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5114916A (es) |
| EP (1) | EP0330049B1 (es) |
| JP (1) | JPH01216939A (es) |
| KR (1) | KR0137476B1 (es) |
| AT (1) | ATE94070T1 (es) |
| AU (1) | AU613154B2 (es) |
| CA (1) | CA1332352C (es) |
| DE (1) | DE68908913T2 (es) |
| DK (1) | DK174978B1 (es) |
| ES (1) | ES2059588T3 (es) |
| IE (1) | IE63656B1 (es) |
| PT (1) | PT89802B (es) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5612456A (en) * | 1988-11-14 | 1997-03-18 | Zymogenetics, Inc. | Factor XIII compositions |
| DE69227042T3 (de) * | 1991-12-31 | 2006-07-27 | Zymogenetics, Inc., Seattle | Verfahren und zusammensetzungen zur verminderung von blutverlust |
| US5525335A (en) * | 1992-04-21 | 1996-06-11 | Ajinomoto Co., Inc. | Wound healing agent |
| WO1994011022A1 (en) * | 1992-11-12 | 1994-05-26 | Zymogenetics, Inc. | Use of topically applied factor xiii for inhibiting hemorrhage |
| JPH07328108A (ja) * | 1994-06-10 | 1995-12-19 | Ajinomoto Co Inc | 生体組織接着剤及び血液凝固剤 |
| DK1100542T3 (da) | 1998-08-06 | 2005-10-17 | Mountain View Pharmaceuticals | PEG-uratoxidasekonjugater og anvendelsen heraf |
| JP2008510476A (ja) * | 2004-08-27 | 2008-04-10 | ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト | 生物学的材料からのｘｉｉｉ因子ポリペプチドの精製 |
| EP1817339B1 (en) * | 2004-11-23 | 2012-01-11 | ZymoGenetics, Inc. | Purification of recombinant human factor xiii |
| TWI418564B (zh) * | 2005-04-11 | 2013-12-11 | Savient Pharmaceuticals Inc | 利用陽離子界面活性劑之蛋白質純化 |
| RU2451074C2 (ru) | 2005-04-11 | 2012-05-20 | Савиент Фармасьютикалз, Инк. | Вариантные формы уратоксидазы и их применение |
| CN101622270B (zh) * | 2006-04-12 | 2014-01-01 | 萨文特医药公司 | 用阳离子表面活性剂纯化蛋白质的方法 |
| NZ597089A (en) | 2009-06-25 | 2014-05-30 | Savient Pharmaceuticals Inc | Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy |
| WO2020160322A1 (en) | 2019-01-30 | 2020-08-06 | Horizon Pharma Rheumatology Llc | Tolerization reduces intolerance to pegloticase and prolongs the urate lowering effect (triple) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3717708A (en) * | 1968-10-24 | 1973-02-20 | Cutter Lab | Blood coagulation complex |
| DE2063070C3 (de) * | 1970-12-22 | 1975-07-24 | Behringwerke Ag, 3550 Marburg | Verfahren zur Herstellung eines Arzneimittels mit fibrinstabilisierender Wirkung |
| DE3622642A1 (de) * | 1986-07-05 | 1988-01-14 | Behringwerke Ag | Einkomponenten-gewebekleber sowie verfahren zu seiner herstellung |
| EP0268772B1 (en) * | 1986-09-19 | 1995-04-26 | ZymoGenetics, Inc. | Expression of biologically active factor XIII |
-
1988
- 1988-02-24 JP JP63039646A patent/JPH01216939A/ja active Granted
-
1989
- 1989-02-14 DE DE89102471T patent/DE68908913T2/de not_active Expired - Lifetime
- 1989-02-14 AT AT89102471T patent/ATE94070T1/de not_active IP Right Cessation
- 1989-02-14 ES ES89102471T patent/ES2059588T3/es not_active Expired - Lifetime
- 1989-02-14 EP EP89102471A patent/EP0330049B1/en not_active Expired - Lifetime
- 1989-02-23 KR KR1019890002127A patent/KR0137476B1/ko not_active IP Right Cessation
- 1989-02-23 DK DK198900838A patent/DK174978B1/da not_active IP Right Cessation
- 1989-02-23 IE IE58089A patent/IE63656B1/en not_active IP Right Cessation
- 1989-02-23 CA CA000591929A patent/CA1332352C/en not_active Expired - Lifetime
- 1989-02-23 AU AU30243/89A patent/AU613154B2/en not_active Expired
- 1989-02-23 PT PT89802A patent/PT89802B/pt not_active IP Right Cessation
-
1990
- 1990-02-14 US US07/480,358 patent/US5114916A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ES2059588T3 (es) | 1994-11-16 |
| US5114916A (en) | 1992-05-19 |
| EP0330049B1 (en) | 1993-09-08 |
| DE68908913D1 (de) | 1993-10-14 |
| CA1332352C (en) | 1994-10-11 |
| JPH01216939A (ja) | 1989-08-30 |
| IE63656B1 (en) | 1995-05-31 |
| PT89802B (pt) | 1994-04-29 |
| AU613154B2 (en) | 1991-07-25 |
| DE68908913T2 (de) | 1994-01-27 |
| EP0330049A2 (en) | 1989-08-30 |
| PT89802A (pt) | 1989-10-04 |
| KR0137476B1 (ko) | 1998-06-01 |
| EP0330049A3 (en) | 1991-01-30 |
| DK83889D0 (da) | 1989-02-23 |
| ATE94070T1 (de) | 1993-09-15 |
| KR890012659A (ko) | 1989-09-18 |
| AU3024389A (en) | 1989-08-24 |
| DK83889A (da) | 1989-08-25 |
| IE890580L (en) | 1989-08-24 |
| JPH0378850B2 (es) | 1991-12-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6825323B2 (en) | Compositions for treatment of hemorrhaging with activated factor VIIa in combination with fibrinogen and methods of using same | |
| DK174978B1 (da) | Anvendelse af human koagulationsfaktor XIII til fremstilling af et lægemiddel til hindring af intraventrikulær blødning hos for tidligt fødte børn | |
| Bernabei et al. | Effect of topical application of nerve-growth factor on pressure ulcers | |
| Getahun et al. | Epidemic of neurolathyrism in Ethiopia | |
| US4451454A (en) | Prophylaxis and treatment of thromboembolic disorders in man and in warm-blooded animals with bicarbonate salts of alkali metals | |
| JPS597693B2 (ja) | 抗トロンビン製剤及びその製法 | |
| US9233126B2 (en) | Platelet-rich plasma compositions | |
| RU2252783C2 (ru) | Фармацевтический препарат, содержащий низкомолекулярный ингибитор тромбина и его пролекарство | |
| DK167738B1 (da) | Fremgangsmaade til fremstilling af en oploesning med hoej specifik rumfangsaktivitet af et protein med vaevs-plasminogenaktivator(t-pa)-aktivitet, oploesning der indeholder protein med t-pa-aktivitet, og anvendelsen af oploesningen inden for human- og veterinaermedicinen | |
| Tso et al. | Venous thrombosis in haemoglobin H disease after splenectomy | |
| CA2091134C (en) | Therapeutic agent for threatened abortion | |
| EP1703913B1 (en) | Use of ribose in recovery from anaesthesia | |
| EP0278416B1 (en) | Use of human blood coagulation factor xiii for the treatment of ulcerative colitis | |
| AU2001227771B2 (en) | Compositions for treatment of hemorrhaging with activated factor VIIa in combination with fibrinogen | |
| KR0184008B1 (ko) | 당뇨병성 괴저 치료제 | |
| Ghareeb et al. | Anti-hemorrhagic agents | |
| AU2001227771A1 (en) | Compositions for treatment of hemorrhaging with activated factor VIIa in combination with fibrinogen | |
| US7074774B2 (en) | Use of N-acetyl-D-glucosamine in the manufacture of pharmaceutical useful for treating cardio-cerebrovascular anoxemia | |
| Fuerth et al. | Surgery in a hemophiliac child with intracranial hemorrhage | |
| JP2526073B2 (ja) | 異常破水治療剤 | |
| JOHNSON et al. | of a Factor VIII Concentrateđ | |
| JakloyazAy | CONGENITAL AFIBRINOGENAEMIA: DIAGNOSIS, CLINICAL FEATURES, FOLLOW-UP STUDY | |
| RU2220720C1 (ru) | Способ профилактики нарушений овариально-менструального цикла и эндокринного бесплодия у женщин репродуктивного возраста с клещевыми нейроинфекциями | |
| JPH01238535A (ja) | 脳動脈瘤破裂防止剤 | |
| CN110960551A (zh) | 新型电解质山梨醇手性复苏药物组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUP | Patent expired |